🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase II, open-label clinical trial with a medicinal product. A total of 30...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-07
Trial ID
NCT03057938
Treatments Being Tested
The research study is being conducted to test how two different types of Po...
Status
Terminated
Location
University of Pennsylvania
Start Date
2019-10-01
Trial ID
NCT04105634
Treatments Being Tested
The main objective of this interdisciplinary study is to develop an underst...
Status
Terminated
Location
Walter Reed National Military Medical Center (WRNMMC)
Start Date
2021-06-07
Trial ID
NCT05337774
Treatments Being Tested
This phase 4 study will explore, in the context of the present French clini...
Status
Completed
Location
Coordinating center (Hôpital de La Timone) and 18 associated centers in France
Start Date
2015-10
Trial ID
NCT02681172
Treatments Being Tested
The primary objectives are to validate that a previously identified gene va...
Status
Active Not Recruiting
Location
Columbia University Irving Medical Center
Start Date
2021-05-11
Trial ID
NCT04840979
Treatments Being Tested
Background: About 5 million adults in the U.S. have Alzheimer s disease or...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2021-08-17
Trial ID
NCT04396873
Treatments Being Tested
The purpose of this research is to better understand how dementia affects a...
Status
Completed
Location
University of Chicago - American School Building
Start Date
2018-08-23
Trial ID
NCT04720001
Treatments Being Tested
The purpose of the study is to learn if Neuraceq™ (Florbetaben F 18 Injecti...
Status
Completed
Location
Dartmouth-Hitchcock Medical Center
Start Date
2017-07-13
Trial ID
NCT05270083
Treatments Being Tested
Amyloidoses are systemic or acquired disorders characterized by the deposit...
Status
Unknown
Location
Fondazione Toscana Gabriele Monasterio
Start Date
2023-01-26
Trial ID
NCT06048601
Treatments Being Tested
Multiple sclerosis (MS) is the most frequently acquired demyelinating disea...
Status
Not Yet Recruiting
Location
Hôpital Neurologique Pierre WERTHEIMER - HCL
Start Date
2024-03
Trial ID
NCT06330077
Treatments Being Tested